XML 66 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Information
 9 Months Ended
Mar. 31, 2015
Segment Reporting [Abstract]  
Segment Information
SEGMENT INFORMATION

The Company’s operations are managed in five operating segments: United States, United Kingdom, Hain Pure Protein (consisting of HPPC and Empire), Canada and Europe. The United States, the United Kingdom and Hain Pure Protein are currently reportable segments, while Canada and Europe do not currently meet the quantitative thresholds for reporting and are therefore combined and reported as “Rest of World.”

Net sales and operating profit are the primary measures used by the Company’s Chief Operating Decision Maker (“CODM”) to evaluate segment operating performance and to decide how to allocate resources to segments. The CODM is the Company’s Chief Executive Officer. Expenses related to certain centralized administration functions that are not specifically related to an operating segment are included in “Corporate and other.” Corporate and other expenses are comprised mainly of the compensation and related expenses of certain of the Company’s senior executive officers and other selected employees who perform duties related to the entire enterprise, as well as expenses for certain professional fees, facilities, and other items which benefit the Company as a whole. Additionally, acquisition related expenses and restructuring charges are included in “Corporate and other.” Expenses that are managed centrally but can be attributed to a segment, such as employee benefits and certain facility costs, are allocated based on reasonable allocation methods. Certain factory start-up costs incurred in Europe that were included in “Corporate and other” in the prior year have been reclassified to the Rest of World segment to conform to the current year presentation. Assets are reviewed by the CODM on a consolidated basis and are not reported by operating segment.

The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented.
 
Three Months Ended March 31,
 
Nine Months Ended March 31,
 
2015
 
2014
 
2015
 
2014
Net Sales:
 
 
 
 
 
 
 
United States
$
343,728

 
$
319,471

 
$
1,034,612

 
$
959,191

United Kingdom
178,068

 
176,939

 
551,144

 
436,985

Hain Pure Protein
83,192

 
—

 
240,078

 
—

Rest of World
57,751

 
61,010

 
164,545

 
173,607

 
$
662,739

 
$
557,420

 
$
1,990,379

 
$
1,569,783

 
 
 
 
 
 
 
 
Operating Income:
 
 
 
 
 
 
 
United States
$
55,851

 
$
56,702

 
$
141,031

 
$
159,578

United Kingdom
11,760

 
18,366

 
29,618

 
32,278

Hain Pure Protein
4,970

 
—

 
16,505

 
—

Rest of World
4,412

 
5,100

 
10,660

 
11,544

 
$
76,993

 
$
80,168

 
$
197,814

 
$
203,400

Corporate and other (1)
(16,799
)
 
(16,539
)
 
(34,781
)
 
(35,686
)
 
$
60,194

 
$
63,629

 
$
163,033

 
$
167,714



(1)
Includes $4,263 and $6,882 of acquisition related expenses, restructuring and integration charges for the three months ended March 31, 2015 and 2014, respectively. Such expenses for the nine months ended March 31, 2015 and 2014 were $5,925 and $9,885, respectively. Corporate and other also includes expense of $280 and a net reduction of expense of $1,936 for contingent consideration adjustments for the nine months ended March 31, 2015 and 2014, respectively. A non-cash impairment charge of $5,510 for the three and nine months ended March 31, 2015 related to a United Kingdom indefinite-lived intangible asset is also included in Corporate and other.


The Company’s long-lived assets, which primarily represent net property, plant and equipment, by geographic area are as follows:
 
March 31,
2015
 
June 30,
2014
United States
$
147,300

 
$
139,919

Canada
11,091

 
9,694

United Kingdom
181,319

 
198,505

Europe
21,391

 
27,746

 
$
361,101

 
$
375,864